USPTO serial 99665652
PICASSO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SWAIN, MICHELE LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with PICASSO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christine Lebron-Dykeman
Christine Lebron-Dykeman McKee, Voorhees & Sease, PLC801 Grand Avenue, Suite 3200Des Moines, IA 50309United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Abstracting services in the nature of extracting and summarizing information from medical, mathematical, and scientific records; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval | ACTIVE | — |
| 042 | Drug discovery services; Pharmaceutical drug development services; Biochemical analysis services in the field of drug discovery; Scientific research in the nature of conducting clinical trials for others; Consulting services for others in the field of design, planning, and implementation project management of scientific research, clinical trials, and clinical trial simulation; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research in the nature of conducting clinical trials for others in the field of New Approach Methodologies (NAM) Development in the field of drug development, drug target discovery, efficacy, and safety testing; Research and development of technology in the field of organoids for use in scientific and medical research and drug development, computer-modeled versions of human beings for use in drug development, and lines of cells for building and validating pre-clinical healthy and disease models as platforms for research and drug development; Providing temporary use of a web-based software application for providing electronic data capture (EDC) of clinical research data; Scientific research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by The Regents of the University of California
- Other trademarks owned by The Regents of the University of California
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named PICASSO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 8, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 2, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 9, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 8, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 1, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2026 | NWAP | NEW APPLICATION ENTERED | — |